348 related articles for article (PubMed ID: 36389673)
1. Impact of Epstein-Barr virus infection in patients with inflammatory bowel disease.
Zhang H; Zhao S; Cao Z
Front Immunol; 2022; 13():1001055. PubMed ID: 36389673
[TBL] [Abstract][Full Text] [Related]
2. Clinical and endoscopic complications of Epstein-Barr virus in inflammatory bowel disease: an illustrative case series.
Goetgebuer RL; van der Woude CJ; de Ridder L; Doukas M; de Vries AC
Int J Colorectal Dis; 2019 May; 34(5):923-926. PubMed ID: 30739187
[TBL] [Abstract][Full Text] [Related]
3. A review on co-existent Epstein-Barr virus-induced complications in inflammatory bowel disease.
Wu S; He C; Tang TY; Li YQ
Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1085-1091. PubMed ID: 31205127
[TBL] [Abstract][Full Text] [Related]
4. Impact of Epstein-Barr virus infection on inflammatory bowel disease (IBD) clinical outcomes.
Núñez Ortiz A; Rojas Feria M; de la Cruz Ramírez MD; Gómez Izquierdo L; Trigo Salado C; Herrera Justiniano JM; Leo Carnerero E
Rev Esp Enferm Dig; 2022 May; 114(5):259-265. PubMed ID: 34315215
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus in inflammatory bowel disease: the spectrum of intestinal lymphoproliferative disorders.
Nissen LH; Nagtegaal ID; de Jong DJ; Kievit W; Derikx LA; Groenen PJ; van Krieken JH; Hoentjen F
J Crohns Colitis; 2015 May; 9(5):398-403. PubMed ID: 25740811
[TBL] [Abstract][Full Text] [Related]
6. Refractory inflammatory bowel disease: is there a role for Epstein-Barr virus? A case-controlled study using highly sensitive Epstein-Barr virus-encoded small RNA1 in situ hybridization.
Pezhouh MK; Miller JA; Sharma R; Borzik D; Eze O; Waters K; Westerhoff MA; Parian AM; Lazarev MG; Voltaggio L
Hum Pathol; 2018 Dec; 82():187-192. PubMed ID: 30120969
[TBL] [Abstract][Full Text] [Related]
7. The Status of Epstein-Barr Virus Infection in Intestinal Mucosa of Chinese Patients with Inflammatory Bowel Disease.
Li X; Chen N; You P; Peng T; Chen G; Wang J; Li J; Liu Y
Digestion; 2019; 99(2):126-132. PubMed ID: 30235444
[TBL] [Abstract][Full Text] [Related]
8. Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement.
Ciccocioppo R; Racca F; Paolucci S; Campanini G; Pozzi L; Betti E; Riboni R; Vanoli A; Baldanti F; Corazza GR
World J Gastroenterol; 2015 Feb; 21(6):1915-26. PubMed ID: 25684960
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-positive mucocutaneous ulcer arising in a post-hematopoietic cell transplant patient followed by polymorphic posttransplant lymphoproliferative disorder and cytomegalovirus colitis.
Satou A; Kohno A; Fukuyama R; Elsayed AA; Nakamura S
Hum Pathol; 2017 Jan; 59():147-151. PubMed ID: 27569297
[TBL] [Abstract][Full Text] [Related]
10. Multicenter, cross-sectional, observational study on Epstein-Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in Japan (EBISU study).
Miura M; Shimizu H; Saito D; Miyoshi J; Matsuura M; Kudo T; Hirayama D; Yoshida M; Arai K; Iwama I; Nakase H; Shimizu T; Hisamatsu T
J Gastroenterol; 2021 Dec; 56(12):1080-1091. PubMed ID: 34591171
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease.
Gehlert T; Devergne O; Niedobitek G
J Med Virol; 2004 Jul; 73(3):432-8. PubMed ID: 15170639
[TBL] [Abstract][Full Text] [Related]
12. Two rare cases of Epstein-Barr virus-associated lymphoproliferative disorders in inflammatory bowel disease patients on thiopurines and other immunosuppressive medications.
Subramaniam K; Cherian M; Jain S; Latimer M; Corbett M; D'Rozario J; Pavli P
Intern Med J; 2013 Dec; 43(12):1339-42. PubMed ID: 24330365
[TBL] [Abstract][Full Text] [Related]
13. Impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease.
de Francisco R; Castaño-García A; Martínez-González S; Pérez-Martínez I; González-Huerta AJ; Morais LR; Fernández-García MS; Jiménez S; Díaz-Coto S; Flórez-Díez P; Suárez A; Riestra S
Aliment Pharmacol Ther; 2018 Oct; 48(7):723-730. PubMed ID: 30095176
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr Virus Status and Subsequent Thiopurine Exposure Within a Paediatric Inflammatory Bowel Disease Population.
Harris RE; Hegde V; Curtis L; Garrick V; Gervais L; Armstrong L; Delahunty C; Eccleston A; Al-Hourani G; Flynn DM; Merrick V; Barclay AR; Tayler R; Hansen R; Russell RK
J Pediatr Gastroenterol Nutr; 2021 Sep; 73(3):358-362. PubMed ID: 34091548
[TBL] [Abstract][Full Text] [Related]
15. Chronic lymphocytic infiltration with pontine perivascular enhancement responsive to steroids (CLIPPERS) and its association with Epstein-Barr Virus (EBV)-related lymphomatoid granulomatosis: a case report.
Dang YL; Kok HK; McKelvie PA; Ligtermoet M; Maddy L; Burrows DA; Crompton DE
BMC Neurol; 2021 Feb; 21(1):80. PubMed ID: 33602163
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression for inflammatory bowel disease does not influence Epstein-Barr viral load in the short-term.
Rodríguez-Lago I; Merino O; López de Goicoechea MJ; Aranzamendi M; Zubiaurre L; Muro N; Ortiz de Zárate J; Cilla G; Cabriada JL
Gastroenterol Hepatol; 2019 Nov; 42(9):542-547. PubMed ID: 31402179
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease exacerbation associated with Epstein-Barr virus infection.
Dimitroulia E; Pitiriga VC; Piperaki ET; Spanakis NE; Tsakris A
Dis Colon Rectum; 2013 Mar; 56(3):322-7. PubMed ID: 23392146
[TBL] [Abstract][Full Text] [Related]
18. Lymphoid and myeloid proliferative disorders associated with inflammatory bowel disease: a clinicopathological study of 15 cases.
Hori Y; Yamamoto H; Kawatoko S; Nozaki Y; Torisu T; Kato K; Koga Y; Miyoshi H; Ohshima K; Tateishi Y; Nakamura S; Kitazono T; Oda Y
Hum Pathol; 2022 Feb; 120():88-98. PubMed ID: 34990621
[TBL] [Abstract][Full Text] [Related]
19. Substantial Epstein-Barr virus reactivation in a case of severe refractory ulcerative colitis: a possible role in exacerbation.
Kato S; Shimizu H; Tomii S; Uchida H; Kawamoto A; Hibiya S; Motobayashi M; Takenaka K; Fujii T; Saito E; Nagahori M; Ohtsuka K; Negi M; Akashi T; Matsuyama T; Kinugasa Y; Watanabe M
Clin J Gastroenterol; 2021 Apr; 14(2):584-588. PubMed ID: 33400186
[TBL] [Abstract][Full Text] [Related]
20. Epstein-barr virus-related diarrhea or exacerbation of inflammatory bowel disease: diagnostic dilemma.
Weinberg I; Neuman T; Margalit M; Ayman F; Wolf DG; Ben-Yehuda A
J Clin Microbiol; 2009 May; 47(5):1588-90. PubMed ID: 19279175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]